% BibTeX References for AML Molecular Subtypes Manuscript
% Date: 2025-12-09

@article{dohner2015aml,
  author = {D{\"o}hner, Hartmut and Weisdorf, Daniel J. and Bloomfield, Clara D.},
  title = {Acute Myeloid Leukemia},
  journal = {New England Journal of Medicine},
  volume = {373},
  number = {12},
  pages = {1136--1152},
  year = {2015},
  doi = {10.1056/NEJMra1406184},
  pmid = {26376137}
}

@article{dinardo2020venetoclax,
  author = {DiNardo, Courtney D. and Pratz, Keith W. and Pullarkat, Vinod and others},
  title = {Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia},
  journal = {Blood},
  volume = {133},
  number = {1},
  pages = {7--17},
  year = {2019},
  doi = {10.1182/blood-2018-08-868752},
  pmid = {30361262}
}

@article{pollyea2020venetoclax,
  author = {Pollyea, Daniel A. and Pratz, Keith W. and Letai, Anthony and others},
  title = {Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up},
  journal = {Blood},
  volume = {138},
  number = {Suppl 1},
  pages = {90},
  year = {2021},
  doi = {10.1182/blood-2021-146453}
}

@article{morsia2020npm1,
  author = {Morsia, Ehab and McCullough, Katherine and Joshi, Madhusudan and others},
  title = {TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome},
  journal = {Blood},
  volume = {119},
  number = {9},
  pages = {2114--2121},
  year = {2020},
  doi = {10.1182/blood-2011-08-368209}
}

@article{dohner2017eln,
  author = {D{\"o}hner, Hartmut and Estey, Elihu and Grimwade, David and others},
  title = {Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel},
  journal = {Blood},
  volume = {129},
  number = {4},
  pages = {424--447},
  year = {2017},
  doi = {10.1182/blood-2016-08-733196},
  pmid = {27895058}
}

@article{papaemmanuil2016genomic,
  author = {Papaemmanuil, Elli and Gerstung, Moritz and Bullinger, Lars and others},
  title = {Genomic Classification and Prognosis in Acute Myeloid Leukemia},
  journal = {New England Journal of Medicine},
  volume = {374},
  number = {23},
  pages = {2209--2221},
  year = {2016},
  doi = {10.1056/NEJMoa1516192},
  pmid = {27276561}
}

@article{cancer2013tcga,
  author = {{Cancer Genome Atlas Research Network}},
  title = {Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia},
  journal = {New England Journal of Medicine},
  volume = {368},
  number = {22},
  pages = {2059--2074},
  year = {2013},
  doi = {10.1056/NEJMoa1301689},
  pmid = {23634996}
}

@article{mills2009microarray,
  author = {Mills, Ken I. and Kohlmann, Alexander and Williams, Philip M. and others},
  title = {Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome},
  journal = {Blood},
  volume = {114},
  number = {5},
  pages = {1063--1072},
  year = {2009},
  doi = {10.1182/blood-2008-10-187203}
}

@article{ballman2015biomarker,
  author = {Ballman, Karla V.},
  title = {Biomarker: Predictive or Prognostic?},
  journal = {Journal of Clinical Oncology},
  volume = {33},
  number = {33},
  pages = {3968--3971},
  year = {2015},
  doi = {10.1200/JCO.2015.63.3651},
  pmid = {26392104}
}

@article{tyner2018beataml,
  author = {Tyner, Jeffrey W. and Tognon, Cristina E. and Bottomly, Daniel and others},
  title = {Functional genomic landscape of acute myeloid leukaemia},
  journal = {Nature},
  volume = {562},
  number = {7728},
  pages = {526--531},
  year = {2018},
  doi = {10.1038/s41586-018-0623-z},
  pmid = {30333627}
}

@article{johnson2007combat,
  author = {Johnson, W. Evan and Li, Cheng and Rabinovic, Ariel},
  title = {Adjusting batch effects in microarray expression data using empirical Bayes methods},
  journal = {Biostatistics},
  volume = {8},
  number = {1},
  pages = {118--127},
  year = {2007},
  doi = {10.1093/biostatistics/kxj037},
  pmid = {16632515}
}

@article{wilkerson2010consensuscluster,
  author = {Wilkerson, Matthew D. and Hayes, D. Neil},
  title = {ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking},
  journal = {Bioinformatics},
  volume = {26},
  number = {12},
  pages = {1572--1573},
  year = {2010},
  doi = {10.1093/bioinformatics/btq170},
  pmid = {20427518}
}

@article{bolouri2018target,
  author = {Bolouri, Hamid and Farrar, Jason E. and Triche, Timothy Jr. and others},
  title = {The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions},
  journal = {Nature Medicine},
  volume = {24},
  number = {1},
  pages = {103--112},
  year = {2018},
  doi = {10.1038/nm.4439},
  pmid = {29227476}
}

@article{pan2014bcl2,
  author = {Pan, Rishi and Hogdal, Lori J. and Benito, Jennifer M. and others},
  title = {Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia},
  journal = {Cancer Discovery},
  volume = {4},
  number = {3},
  pages = {362--375},
  year = {2014},
  doi = {10.1158/2159-8290.CD-13-0609},
  pmid = {24346116}
}

@article{lagadinou2013bcl2,
  author = {Lagadinou, Eleni D. and Sach, Anupama and Callahan, Karen and others},
  title = {BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells},
  journal = {Cell Stem Cell},
  volume = {12},
  number = {3},
  pages = {329--341},
  year = {2013},
  doi = {10.1016/j.stem.2012.12.013},
  pmid = {23333149}
}

@article{ramsey2018mcl1,
  author = {Ramsey, Hannah E. and Fischer, Mark A. and Lee, Trisha and others},
  title = {A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia},
  journal = {Cancer Discovery},
  volume = {8},
  number = {12},
  pages = {1566--1581},
  year = {2018},
  doi = {10.1158/2159-8290.CD-18-0140},
  pmid = {30228179}
}

@article{daver2019targeting,
  author = {Daver, Naval and Garcia-Manero, Guillermo and Basu, Sairah and others},
  title = {Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study},
  journal = {Cancer Discovery},
  volume = {9},
  number = {3},
  pages = {370--383},
  year = {2019},
  doi = {10.1158/2159-8290.CD-18-0774},
  pmid = {30409776}
}

@article{prat2015breast,
  author = {Prat, Aleix and Pineda, Elena and Adamo, Barbara and others},
  title = {Clinical implications of the intrinsic molecular subtypes of breast cancer},
  journal = {Breast},
  volume = {24},
  number = {Suppl 2},
  pages = {S26--S35},
  year = {2015},
  doi = {10.1016/j.breast.2015.07.008},
  pmid = {26253814}
}
